VMD
Viemed Healthcare, Inc. NASDAQ Listed Aug 9, 2019$9.84
After hrs
$9.84
+0.00%
Mkt Cap $377.0M
52w Low $6.05
57.7% of range
52w High $12.61
50d MA $11.05
200d MA $8.81
P/E (TTM)
30.9x
EV/EBITDA
10.4x
P/B
2.7x
Debt/Equity
0.1x
ROE
10.5%
P/FCF
33.7x
RSI (14)
43.60
ATR (14)
$0.36
Beta
1.16
50d MA
$11.05
200d MA
$8.81
Avg Volume
339.6K
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
625 East Kaliste Saloom Road · Lafayette, LA 70508 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | AMC | 0.12 | 0.07 | -41.7% | — | — | — | — | — | — | — | — |
| May 5, 2026 | AMC | 0.09 | 0.06 | -33.3% | 9.70 | -4.3% | -12.2% | +8.1% | -2.9% | +1.0% | +3.7% | — |
| Mar 4, 2026 | AMC | 0.12 | 0.14 | +16.7% | 9.08 | -11.8% | -7.5% | +4.5% | +5.8% | +2.3% | -4.4% | — |
| Nov 5, 2025 | AMC | 0.09 | 0.09 | +0.0% | 6.43 | -2.0% | -2.6% | +1.8% | +0.3% | -0.6% | +3.1% | — |
| Aug 6, 2025 | AMC | 0.09 | 0.08 | -5.9% | 6.45 | +4.8% | +7.9% | +2.0% | +2.7% | +2.1% | -1.5% | — |
| May 7, 2025 | AMC | 0.06 | 0.06 | +0.0% | 7.27 | +0.0% | -11.7% | -1.6% | +3.0% | +5.8% | -0.3% | — |
| Mar 10, 2025 | AMC | 0.11 | 0.10 | -9.1% | 7.40 | +0.0% | +5.4% | +0.1% | -1.3% | -1.8% | -2.1% | — |
| Nov 6, 2024 | AMC | 0.08 | 0.10 | +25.0% | 9.14 | +5.5% | -1.5% | +0.8% | +4.9% | -1.2% | -2.7% | — |
| Aug 7, 2024 | AMC | 0.07 | 0.04 | -42.9% | 6.53 | -2.0% | +10.0% | +1.1% | -2.8% | +0.4% | +0.0% | — |
| May 6, 2024 | AMC | 0.07 | 0.04 | -42.9% | 8.22 | -0.2% | -6.8% | -5.1% | -1.9% | +0.3% | -1.4% | — |
| Mar 6, 2024 | AMC | 0.10 | 0.09 | -10.0% | 9.38 | +1.9% | +6.5% | -0.8% | -5.8% | +1.5% | +0.0% | — |
| Nov 1, 2023 | AMC | 0.09 | 0.07 | -22.2% | 6.07 | -0.7% | +12.0% | +10.0% | -6.0% | +1.0% | -2.3% | — |
| Aug 9, 2023 | AMC | 0.05 | 0.06 | +20.0% | 8.34 | +3.2% | -3.7% | +2.9% | -0.1% | -0.5% | -2.3% | — |
| May 8, 2023 | AMC | 0.04 | 0.04 | +0.0% | 10.79 | +1.9% | -2.7% | +1.5% | -2.5% | +0.0% | +4.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3 | RBC Capital | Maintains | Outperform → Outperform | — | $5.64 | $5.61 | -0.5% | +3.2% | -2.1% | +6.7% | -0.2% | +0.2% |
| Mar 5 | RBC Capital | Maintains | Outperform → Outperform | — | $9.70 | $9.81 | +1.1% | -1.1% | +0.2% | +4.8% | -1.2% | +4.0% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Frazier WilliamDir/Off | Chief Medical Officer | Sell | 10,000 | $11.72 | $117K | 73,214 | -2.06% | +0.92% |
| Jun 24, 2026 | Smokoff TimothyDir | — | Sell | 5,000 | $11.56 | $58K | 85,518 | -2.06% | +0.92% |
| Jun 24, 2026 | Smokoff TimothyDir | — | Sell | 3,364 | $11.50 | $39K | 90,518 | -2.06% | +0.92% |
| Jun 24, 2026 | Smokoff TimothyDir | — | Sell | 1,636 | $11.48 | $19K | 93,882 | -2.06% | +0.92% |
8-K · 2.02
!! High
Viemed Healthcare, Inc. -- 8-K 2.02: Earnings Results
Viemed Healthcare reported Q2 and H1 2026 financial results, providing investors visibility into operational performance and financial condition during the first half of the year.
Aug 3
8-K · 5.02
!!! Very High
Viemed Healthcare, Inc. -- 8-K 5.02: Executive Change
Jun 4
8-K · 7.01
! Medium
Viemed Healthcare, Inc. -- 8-K 7.01: Regulation FD Disclosure
Viemed Healthcare released an investor presentation available on its website, providing summary information that should be considered alongside SEC filings and future public announcements.
Jun 2
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Viemed disclosed an investor presentation in March 2026, suggesting potential strategic announcements or capital allocation plans that could significantly impact shareholder value or market perception.
Mar 16
8-K · 8.01
!! High
Viemed Healthcare, Inc. Common Shares -- 8-K 8.01: Material Event / Announcement
Viemed Healthcare's material announcement has been incorporated into its 8-K filing, though the specific details require reviewing the attached press release exhibit for investor impact assessment.
Mar 4
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 1,303,384 | $12M | New | Mar 2026 |
| 2 | First Eagle Investment Management, Llc | 1,059,314 | $10M | Added | Mar 2026 |
| 3 | Arrowstreet Capital, Limited Partnership | 711,186 | $7M | Added | Mar 2026 |
| 4 | Morgan Stanley | 585,542 | $4M | Added | Dec 2025 |
| 5 | Tocqueville Asset Management L.p. | 472,100 | $4M | — | Mar 2026 |
| 6 | Panagora Asset Management Inc | 472,097 | $4M | Added | Mar 2026 |
| 7 | Renaissance Technologies Llc | 442,200 | $4M | — | Mar 2026 |
| 8 | Two Sigma Investments, Lp | 413,394 | $4M | Added | Mar 2026 |
| 9 | Martin & Co Inc /tn/ | 273,001 | $3M | New | Mar 2026 |
| 10 | Northern Trust Corp | 251,387 | $2M | Added | Mar 2026 |
| 11 | Vanguard Portfolio Management Llc | 243,023 | $2M | New | Mar 2026 |
| 12 | Ubs Group Ag | 217,808 | $2M | Added | Mar 2026 |
| 13 | Rice Hall James & Associates, Llc | 230,382 | $2M | Added | Dec 2025 |
| 14 | Acadian Asset Management Llc | 165,287 | $2M | Added | Mar 2026 |
| 15 | Bnp Paribas Financial Markets | 142,605 | $1M | Added | Mar 2026 |
| 16 | Expect Equity Llc | 173,970 | $1M | Added | Dec 2025 |
| 17 | Rbf Capital, Llc | 131,944 | $1M | — | Mar 2026 |
| 18 | Point72 Asset Management | 129,479 | $1M | Added | Mar 2026 |
| 19 | Jpmorgan Chase & Co | 114,343 | $1M | Reduced | Mar 2026 |
| 20 | Aqr Capital Management Llc | 113,740 | $1M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$377.0M
Enterprise Value
$475.0M
P/E (TTM)
30.91x
Forward P/E
20.49x
PEG Ratio
0.62x
P/B
2.67x
P/S
1.33x
P/FCF
33.65x
EV/EBITDA
10.42x
Shares Out
40.8M
Financials (TTM)
Revenue
$301.6M
Net Income
$14.5M
EBITDA
$45.6M
Free Cash Flow
$11.9M
Op Cash Flow
$51.9M
EPS Basic
$0.38
EPS Diluted
$0.36
EPS Forward
$0.48
Gross Margin
57.3%
Op Margin
8.0%
Net Margin
4.8%
Balance Sheet
Total Assets
$214.9M
Total Liab.
$71.4M
Total Equity
$143.5M
Cash
$13.5M
LT Debt
$11.3M
Book Value/Sh
$3.69
Debt/Equity
0.11x
Current Ratio
1.18
Quick Ratio
1.06
Returns & Growth
ROE
10.5%
ROA
7.5%
ROIC
8.8%
Rev Growth YoY
+20.5%
EPS Growth YoY
+31.0%
Price Returns
2W
-2.3%
1M
-3.6%
3M
+23.3%
6M
+44.3%
12M
+92.6%
Technicals
52W High
$12.61
52W Low
$6.05
50d MA
$11.05
200d MA
$8.81
RSI (14)
43.60
ATR (14)
$0.36
Beta
1.16
Avg Volume
340K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 27, 2026 7:54am
· Source: financialmodelingprep.com